What is Abaxis?
Founded in 1989 and headquartered in Union City, California, Abaxis is a global entity focused on the development, manufacturing, and marketing of portable blood analysis systems. These systems are designed for rapid blood constituent measurements, serving a broad spectrum of medical specialties in both human and veterinary patient care. The company's mission centers on enhancing the efficiency of care delivery and improving the quality of life for patients through its innovative diagnostic solutions.
How much funding has Abaxis raised?
Abaxis has raised a total of $23.9M across 1 funding round:
Stock Offering
$23.9M
Stock Issuance/Offering (1992): $23.9M, investors not publicly disclosed
What's next for Abaxis?
The context of 'major enterprise-level funding' and 'major strategic investment' suggests Abaxis has historically pursued significant capital infusions to fuel its growth and market penetration. While specific details of recent strategic backing are represented by placeholders, such investments typically signal a phase of scaling operations, expanding product lines, or entering new geographical markets. The company's focus on portable diagnostics positions it to capitalize on the increasing demand for point-of-care testing in both clinical and field settings.
See full Abaxis company page
